Funder: National Institutes of Health
Due Dates: May 7, 2025 | September 7, 2025 | January 7, 2026 | May 7, 2026 | September 7, 2026
Funding Amounts: Up to $275,000 in direct costs over 2 years (no more than $200,000 in any single year).
Summary: Supports exploratory research on HIV cure strategies administered at the start of antiretroviral therapy (ART) or at ART restart, aiming for sustained treatment-free remission.
Key Information: Clinical trials are not allowed; foreign and domestic applicants are eligible; updated March 31, 2025—review full NOFO for changes.